Basics of Compounding: Considerations for Implementing USP Chapter <797> Pharmacy Compounding -- Sterile Preparations, Part 20: Patient or Caregiver Training, Patient Monitoring and Adverse Events Reporting, and Quality-Assurance Program

Author(s):  Okeke Claudia C, Allen Loyd V Jr

Issue:  Jul/Aug 2010 - Sterile Compounding
View All Articles in Issue

Abstract:  This article is intended to address the activities of the caregiver and encourage the need to address adverse events or medical errors. The advantage of disclosing adverse events or medication errors is to avoid further potential errors and determine/correct the cause of the errors. There should be awareness between patients and caregivers on the proper use and administration of intended compounded sterile preparations. Patients/patient’s relatives should ask questions about their medications and be knowledgeable or cognizant on the appearance of the preparation or specified dosage of the medication. Caregivers should be open and explicit about the medications being administered or prescribed by the doctor and the rationale for such medications. This module will address these sections in a practical manner and provide practice clarification to the standards.

Related Keywords: United States Pharmacopeia, USP Chapter <797> Pharmaceutical Compounding -- Sterile Preparations, quality assurance, patient education, patient monitoring, adverse event reporting, drug errors

Related Categories: STERILE PREPARATIONS, QUALITY CONTROL, PATIENT EDUCATION, UNITED STATES PHARMACOPEIA CONVENTIONS, ADVERSE DRUG EVENTS

Purchase this article for download in electronic PDF format from IJPC at for $75 at:
https://ijpc.com/Abstracts/Abstract.cfm?ABS=3163

Search the entire IJPC archive by keyword, topic, or issue at:
https://ijpc.com/Products